Danaher | Actif À Court Terme



Current Assets Changement Date
Abbott USD 23.15B 503M 2025-03
Agilent USD 4.21B 101M 2025-04
Align Technology USD 2.4B 90.41M 2025-03
Becton, Dickinson and Co. USD 8.67B 7M 2025-03
Bio Techne USD 627.24M 7.4M 2025-03
Bio-Rad Laboratories USD 3.04B 6.3M 2025-03
Boston Scientific USD 7.34B 415M 2025-03
Bruker USD 2.11B 53.2M 2025-03
Charles River Laboratories USD 1.51B 103.29M 2025-03
Danaher USD 9.52B 28M 2025-03
Dentsply International USD 1.98B 232M 2025-03
Edwards Lifesciences USD 6.29B 442.3M 2024-12
ESCO Technologies USD 660.75M 15.24M 2025-03
Exact Sciences USD 1.37B 201.08M 2025-03
Fortive USD 2.7B 111.8M 2025-03
Henry Schein USD 4.04B 54M 2025-03
Hologic USD 3.21B 284.9M 2025-03
Illumina USD 2.67B 73M 2025-03
Intuitive Surgical USD 11.88B 331.3M 2025-03
IQVIA Holdings USD 5.91B 82M 2025-03
Keysight Technologies USD 5.48B 1.02B 2025-04
Laboratory Of America USD 3.79B 1.02B 2025-03
Medtronic USD 23.81B 1.3B 2025-04
Mettler Toledo International USD 1.16B 29.11M 2025-03
Myriad Genetics USD 287.2M 10.8M 2025-03
Quest Diagnostics USD 2.08B 317M 2025-03
Quidel USD 1.26B 39.3M 2025-03
Repligen USD 1.03B 33.58M 2025-03
Revvity USD 2.32B 31.67M 2025-03
Roper Industries USD 1.7B 161.9M 2025-03
Stryker USD 13.02B 1.83B 2025-03
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
Waters USD 1.74B 70.77M 2025-03
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Danaher Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.